To our knowledge, this is the first demonstration in an animal model of the pathological effect of LRRK2 in glial cells, leading to severe inflammation and neurodegeneration, strongly supporting the hypothesis of a non-cell autonomous disease mechanism for PD associated with LRRK2 pathological mutations. Here, LRRK2 is linked to Parkinson disease.